litlas
ログインアカウント作成

David M. Livermore

1987–2025 年に発表

187
論文数
41,409
被引用数
114
h 指数
184
i10 指数

被引用数

David M. Livermore の年別被引用数1987 年: 被引用 3 件1990 年: 被引用 1 件1991 年: 被引用 7 件1992 年: 被引用 6 件1993 年: 被引用 10 件1994 年: 被引用 22 件1995 年: 被引用 31 件1996 年: 被引用 40 件1997 年: 被引用 50 件1998 年: 被引用 57 件1999 年: 被引用 83 件2000 年: 被引用 89 件2001 年: 被引用 148 件2002 年: 被引用 153 件2003 年: 被引用 191 件2004 年: 被引用 253 件2005 年: 被引用 302 件2006 年: 被引用 288 件2007 年: 被引用 217 件2008 年: 被引用 282 件2009 年: 被引用 286 件2010 年: 被引用 334 件2011 年: 被引用 528 件2012 年: 被引用 532 件2013 年: 被引用 579 件2014 年: 被引用 559 件2015 年: 被引用 536 件2016 年: 被引用 507 件2017 年: 被引用 471 件2018 年: 被引用 385 件2019 年: 被引用 1,332 件2020 年: 被引用 1,315 件2021 年: 被引用 1,205 件2022 年: 被引用 926 件2023 年: 被引用 584 件2024 年: 被引用 917 件2025 年: 被引用 472 件2026 年: 被引用 10 件1988〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,508 件、この内訳の 16.9%イギリス: 引用元論文 1,290 件、この内訳の 8.7%中国: 引用元論文 1,233 件、この内訳の 8.3%フランス: 引用元論文 758 件、この内訳の 5.1%スペイン: 引用元論文 605 件、この内訳の 4.1%イタリア: 引用元論文 563 件、この内訳の 3.8%オーストラリア: 引用元論文 537 件、この内訳の 3.6%ドイツ: 引用元論文 533 件、この内訳の 3.6%インド: 引用元論文 478 件、この内訳の 3.2%カナダ: 引用元論文 438 件、この内訳の 2.9%スイス: 引用元論文 314 件、この内訳の 2.1%オランダ: 引用元論文 284 件、この内訳の 1.9%
0%16.9%その他 35.8%

機関

分野

  • Biochemistry, Genetics and Molecular Biology66.7%
  • Medicine15.2%
  • Immunology and Microbiology7.3%
  • Environmental Science5.3%
  • Agricultural and Biological Sciences1.7%
  • Engineering0.8%
  • その他3%

トピック

  • Antibiotic Resistance in Bacteria23.8%
  • Antibiotics Pharmacokinetics and Efficacy7.1%
  • Antibiotic Use and Resistance5.8%
  • Pharmaceutical and Antibiotic Environmental Impacts5.7%
  • Bacterial Identification and Susceptibility Testing4.4%
  • Bacterial biofilms and quorum sensing3.8%
  • その他49.4%

共著者

全論文

検索で開く
  1. Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection

    著者: Themoula Charalampous, Gemma L. Kay, Hollian Richardson, Alp Aydin, Rossella Baldan, Christopher Jeanes, Duncan Rae, Sara J. Grundy, Daniel J. Turner, John Wain, Richard M. Leggett, David M. Livermore, Justin O’Grady - Nature Biotechnology 2019 被引用: 723

  2. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

    著者: L. Silvia Muñoz-Price, Laurent Poirel, Robert A. Bonomo, Mitchell J. Schwaber, George L. Daikos, Martin Cormican, Giuseppe Cornaglia, Javier Garau, Marek Gniadkowski, Mary K. Hayden, Kanimozhi Kumarasamy, David M. Livermore, Juan José Maya, Patrice Nordmann, Jean B. Patel, David L. Paterson, Johann Pitout, María Virginia Villegas, Hui Wang, Neil Woodford, John P. Quinn - The Lancet Infectious Diseases 2013 被引用: 1,650

  3. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

    著者: Kanimozhi Kumarasamy, Mark A. Toleman, Timothy R. Walsh, Jay Bagaria, Fafhana Butt, Ravi Balakrishnan, Uma Chaudhary, Michel Doumith, Christian G. Giske, Seema Irfan, Padma Krishnan, Anil Kumar, Sunil Maharjan, Shazad Mushtaq, Tabassum Noorie, David L. Paterson, A. Pearson, Claire Perry, Rachel Pike, Bhargavi Rao, Ujjwayini Ray, Jayanta Sarma, Madhu Sharma, Elizabeth Sheridan, M. A. Thirunarayan, Jane F. Turton, Supriya Upadhyay, Marina Warner, William Welfare, David M. Livermore, Neil Woodford - The Lancet Infectious Diseases 2010 被引用: 2,915

  4. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

    著者: Hajo Grundmann, Corinna Glasner, Barbara Albiger, David M. Aanensen, Christopher Tomlinson, Arjana Tambić Andrašević, Rafael Cantón, Yehuda Carmeli, Alexander W. Friedrich, Christian G. Giske, Y. Glupczynski, Marek Gniadkowski, David M. Livermore, Patrice Nordmann, Laurent Poirel, Gian María Rossolini, Harald Seifert, Alkiviadis Vatopoulos, Timothy R. Walsh, Neil Woodford, Dominique L. Monnet, Andi Koraqi, Denada Lacej, Petra Apfalter, Rainer Hartl, Y. Glupczynski, Te‐Din Huang, Tanya Strateva, Yuliya Marteva-Proevska, Arjana Tambić Andrašević, Iva Butić, Despo Pieridou-Bagatzouni, Panagiota Maikanti-Charalampous, Jaroslav Hrabák, Helena Žemličková, Anette M. Hammerum, Lotte Jakobsen, Marina Ivanova, Anastasia Pavelkovich, Jari Jalava, Monica Österblad, Laurent Dortet, Sophie Vaux, Martin Kaase, Sören Gatermann, Alkiviadis Vatopoulos, Kyriaki Tryfinopoulou, Ákos Tóth, Laura Jánvári, Teck Wee Boo, Elaine McGrath, Yehuda Carmeli, Amos Adler, Annalisa Pantosti, Monica Monaco, Lul Raka, Arsim Kurti, Arta Balode, Māra Saule, Jolanta Miciulevičienė, Aistė Mierauskaitė, Monique Perrin-Weniger, Paul Reichert, Nina Nestorova, Sonia Debattista, Gordana Mijović, Milena Lopičić, Ørjan Samuelsen, Bjørg Haldorsen, Dorota Żabicka, Elżbieta Literacka, Manuela Caniça, Vera Manageiro, Ana Kaftandzieva, Elena Trajkovska-Dokic, Maria Damian, Brânduşa Elena Lixandru, Zora Jelesić, Anika Trudić, M Nikś, Eva Schréterová, Mateja Pirš, Tjaša Cerar, Jesús Oteo, Belén Aracil, Christian G. Giske, Karin Sjöström, Deniz Gür, Aslı Çakar, Neil Woodford, Katie L. Hopkins, Camilla Wiuff, Derek Brown - The Lancet Infectious Diseases 2016 被引用: 677

  5. Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline

    著者: Sara E. Boyd, David M. Livermore, David C. Hooper, William Hope - Antimicrobial Agents and Chemotherapy 2020 被引用: 291

  6. OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline

    著者: Sara E. Boyd, Alison Holmes, Richard Peck, David M. Livermore, William Hope - Antimicrobial Agents and Chemotherapy 2022 被引用: 157

  7. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study

    著者: Timothy R. Walsh, Janis Weeks, David M. Livermore, Mark A. Toleman - The Lancet Infectious Diseases 2011 被引用: 1,239

  8. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia

    著者: Diana Averbuch, Christina Orasch, Catherine Cordonnier, David M. Livermore, Małgorzata Mikulska, Claudio Viscoli, Inge C. Gyssens, Winfried V. Kern, G. A. Klyasova, Oscar Marchetti, Dan Engelhard, Murat Akova, on behalf of ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN - Haematologica 2013 被引用: 635

  9. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

    著者: Rafael Cantón, Murat Akova, Yehuda Carmeli, Christian G. Giske, Y. Glupczynski, Marek Gniadkowski, David M. Livermore, Vivì Miriagou, Thierry Naas, Gian María Rossolini, Ørjan Samuelsen, Harald Seifert, Neil Woodford, Patrice Nordmann - Clinical Microbiology and Infection 2012 被引用: 881

  10. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance

    著者: Neil Woodford, Jane F. Turton, David M. Livermore - FEMS Microbiology Reviews 2011 被引用: 877

  11. Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study

    著者: Michaela Day, Katie L. Hopkins, David W Wareham, Mark A. Toleman, Nicola Elviss, Luke Randall, Christopher Teale, Paul Cleary, Camilla Wiuff, Michel Doumith, Matthew J. Ellington, Neil Woodford, David M. Livermore - The Lancet Infectious Diseases 2019 被引用: 210

  12. Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli

    著者: David M. Livermore, Shazad Mushtaq, Anna Vickers, Neil Woodford - International Journal of Antimicrobial Agents 2023 被引用: 59

  13. Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study

    著者: Virve I. Enne, Alp Aydin, Rossella Baldan, Dewi R Owen, Hollian Richardson, Federico Ricciardi, Charlotte Russell, Brenda O. Nomamiukor-Ikeji, Ann-Marie Swart, Juliet High, Antony Colles, Julie Barber, Vanya Gant, David M. Livermore, Justin O’Grady - Thorax 2022 被引用: 114

  14. beta-Lactamases in laboratory and clinical resistance.

    著者: David M. Livermore - Clinical Microbiology Reviews 1995 被引用: 1,731

  15. The emerging NDM carbapenemases

    著者: Patrice Nordmann, Laurent Poirel, Timothy R. Walsh, David M. Livermore - Trends in Microbiology 2011 被引用: 649

  16. Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria

    著者: Shazad Mushtaq, Anna Vickers, Michel Doumith, Matthew J. Ellington, Neil Woodford, David M. Livermore - Journal of Antimicrobial Chemotherapy 2020 被引用: 58

  17. Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing

    著者: Katrin Schmidt, Solomon Mwaigwisya, Lisa Crossman, Michel Doumith, David J. Munroe, Carlos Pires, Arshad Khan, Neil Woodford, Nigel J. Saunders, John Wain, Justin O’Grady, David M. Livermore - Journal of Antimicrobial Chemotherapy 2016 被引用: 331

  18. In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii

    著者: David M. Livermore, Shazad Mushtaq, Marina Warner, Neil Woodford - Antimicrobial Agents and Chemotherapy 2016 被引用: 150

  19. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa

    著者: David M. Livermore, M. Warner, Shazad Mushtaq - Journal of Antimicrobial Chemotherapy 2013 被引用: 271

  20. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’

    著者: Akihiro Morinaka, Yuko Tsutsumi, Mototsugu Yamada, Kenji Suzuki, Takashi Watanabe, Takao Abé, Takeshi Furuuchi, Seiichi Inamura, Yoshiaki Sakamaki, Nakako Mitsuhashi, Takashi Ida, David M. Livermore - Journal of Antimicrobial Chemotherapy 2015 被引用: 171

  21. Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against β-lactam antibiotics

    著者: Régis Stentz, Nikki Horn, Kathryn Cross, Louise J. Salt, Charles A. Brearley, David M. Livermore, Simon R. Carding - Journal of Antimicrobial Chemotherapy 2014 被引用: 127

  22. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii

    著者: Jane F. Turton, M. E. Ward, Neil Woodford, Mary E. Kaufmann, Rachel Pike, David M. Livermore, Tyrone L. Pitt - FEMS Microbiology Letters 2006 被引用: 755

  23. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients

    著者: Małgorzata Mikulska, Claudio Viscoli, Christina Orasch, David M. Livermore, Diana Averbuch, Catherine Cordonnier, Murat Akova - Journal of Infection 2013 被引用: 306

  24. In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria

    著者: Shazad Mushtaq, Zahra Sadouki, Anna Vickers, David M. Livermore, Neil Woodford - Antimicrobial Agents and Chemotherapy 2020 被引用: 109